“What do I think about implementing lung cancer screening? It all depends on how.” Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors
PLOS ONE · 05.04.2023 · 18 (4) · e0283939
DOI: 10.1371/journal.pone.0283939 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 05.04.2023. Verfasst von Rachael H Dodd und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Daffodil Centre, A Joint Venture Between Cancer Council NSW and The University of Sydney, Faculty of Medicine and Health, The University of Sydne…. Hauptthemen laut MEDLINE: Early Detection of Cancer, Lung Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian National Health and Medical Research Council, Metro North Hospital and Health Service.
Abstract (Originalsprache)
Background
Lung cancer is the number one cause of cancer death worldwide. Although international trials demonstrate that targeted screening using low dose computed tomography (LDCT) significantly reduces lung cancer mortality, implementation of screening in the high-risk population presents complex health system challenges that need to be thoroughly understood to support policy change.
Aim
To elicit health care providers’ and policymakers’ views about the acceptability and feasibility of lung cancer screening (LCS) and barriers and enablers to implementation in the Australian setting.
Methods
We conducted 24 focus groups and three interviews (22 focus groups and all interviews online) in 2021 with 84 health professionals, researchers, and current cancer screening program managers and policy makers across all Australian states and territories. Focus groups included a structured presentation about lung cancer and screening and lasted approximately one hour each. A qualitative approach to analysis was used to map topics to the Consolidated Framework for Implementation Research.
Results
Nearly all participants considered LCS to be acceptable and feasible but identified a wide range of implementation challenges. Topics (five specific to health systems and five cross-cutting with participant factors) identified were mapped to CFIR constructs, of which ‘readiness for implementation’, ‘planning’ and ‘executing’ were most salient. Health system factor topics included delivery of the LCS program, cost, workforce considerations, quality assurance and complexity of health systems. Participants strongly advocated for streamlined referral processes. Practical strategies to address equity and access, such as using mobile screening vans, were emphasised.
Conclusions
Key stakeholders readily identified the complex challenges associated with the acceptability and feasibility of LCS in Australia. The barriers and facilitators across health system and cross-cutting topics were clearly elicited. These findings are highly relevant to the scoping of a national LCS program by the Australian Government and a subsequent recommendation for implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Daffodil Centre, A Joint Venture Between Cancer Council NSW and The University of Sydney, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
- University of Queensland Thoracic Research Centre and Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia.
- Collaboration for Cancer Outcomes, Research and Evaluation, Ingham Institute, UNSW Sydney, Liverpool, New South Wales, Australia.
- Liverpool and Macarthur Cancer Therapy Centres, Western Sydney University, Campbelltown, New South Wales, Australia.
- George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Nicole M Rankin
Förderung
- Australian National Health and Medical Research Council
- Metro North Hospital and Health Service
Zitieren
APA
Dodd, R. H., Sharman, A. R., Marshall, H. M., Yap, M. L., Stone, E., Rhee, J., McCullough A O M, S., & Rankin, N. M. (2023). “What do I think about implementing lung cancer screening? It all depends on how.” Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors. PLOS ONE, 18(4), e0283939. https://doi.org/10.1371/journal.pone.0283939
Vancouver
Dodd RH, Sharman AR, Marshall HM, Yap ML, Stone E, Rhee J, et al. “What do I think about implementing lung cancer screening? It all depends on how.” Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors. PLOS ONE. 2023;18(4):e0283939. doi:10.1371/journal.pone.0283939
BibTeX
@article{Dodd2023,
author = {Dodd, Rachael H and Sharman, Ashleigh R and Marshall, Henry M and Yap, Mei Ling and Stone, Emily and Rhee, Joel and McCullough A O M, Sue and Rankin, Nicole M},
title = {“What do I think about implementing lung cancer screening? It all depends on how.” Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {4},
pages = {e0283939},
doi = {10.1371/journal.pone.0283939}
}
EUVIMED